These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19106908)

  • 1. [Characteristics of the patients included in the French cohort of patients with emphysema caused by alpha-1 antitrypsin deficiency].
    Thabut G; Mornex JF; Cuvelier A; Padrazzi B; Pison C; Neukirch F; Lafitte JJ; Boczkowski J; Balduyck M; Muir JF; Carles P; Fournier M
    Rev Mal Respir; 2008 Nov; 25(9):1115-22. PubMed ID: 19106908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experience.
    Gauvain C; Mornex JF; Pison C; Cuvelier A; Balduyck M; Pujazon MC; Fournier M; AitIlalne B; Thabut G
    COPD; 2015 May; 12 Suppl 1():46-51. PubMed ID: 25938292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.
    Lieberman J
    Chest; 2000 Nov; 118(5):1480-5. PubMed ID: 11083705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained.
    Sclar DA; Evans MA; Robison LM; Skaer TL
    Clin Drug Investig; 2012 May; 32(5):353-60. PubMed ID: 22480280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin. Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL)-alpha1-AT-study group.
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Eur Respir J; 1998 Feb; 11(2):428-33. PubMed ID: 9551749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmentation therapy with alpha-1 antitrypsin: 20 year- follow-up of a deficient patient].
    Pujazon MC; Carles P
    Rev Mal Respir; 2008 Nov; 25(9):1136-41. PubMed ID: 19106912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α1-Antitrypsin Deficiency.
    Hatipoğlu U; Stoller JK
    Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.
    Dirksen A; Friis M; Olesen KP; Skovgaard LT; Sørensen K
    Acta Radiol; 1997 Sep; 38(5):826-32. PubMed ID: 9332238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency.
    Parr DG; Dirksen A; Piitulainen E; Deng C; Wencker M; Stockley RA
    Respir Res; 2009 Aug; 10(1):75. PubMed ID: 19678952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha-1 antitrypsin deficiency 50 years later].
    Mornex JF
    Bull Acad Natl Med; 2014; 198(4-5):757-66. PubMed ID: 26753407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis.
    Campos MA; Runken MC; Davis AM; Johnson MP; Stone GA; Buikema AR
    Adv Ther; 2018 Apr; 35(4):467-481. PubMed ID: 29616482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?
    Schwaiblmair M; Vogelmeier C
    Drugs Aging; 1998 Jun; 12(6):429-40. PubMed ID: 9638392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha 1-antitrypsin deficiency].
    Mornex JF
    Rev Mal Respir; 2022 Oct; 39(8):698-707. PubMed ID: 35715315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of the alpha-1 antitrypsin deficiency registry in Belgium.
    Hutsebaut J; Janssens W; Louis R; Willersinn F; Stephenne X; Sokal E; Derom E
    COPD; 2015 May; 12 Suppl 1():10-4. PubMed ID: 25938285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [National cohort of patients with emphysema and alpha-1 antitrypsin deficiency].
    Thabut G
    Rev Mal Respir; 2005 Dec; 22(6 Pt 1):1053-7. PubMed ID: 16234760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Emphysema due to alpha-1-antitrypsin deficiency: is it really an uncommon disease?].
    Miravitlles M
    Med Clin (Barc); 2004 Dec; 123(20):778-9. PubMed ID: 15607070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.